AIM: To evaluate the association between lower urinary tract symptoms (LUTS) severity and bladder wall thickness (BWT). MATERIALS AND METHODS: The study included 155 patients referred to outpatient clinics for LUTS. Patients were divided into three groups due to their IPSS. Group A included the patients with mild symptoms, group B included patients with moderate symptoms and group C included patients with severe symptoms. The patients were again divided into two groups due to their uroflowmetry results. Group 1 included the patients whose Q (max) </= 10 ml/s and group 2 included the patients whose Q (max) > 10 ml/s. RESULTS: The mean BWT was 4.14 + 1.03 mm (from 3 to 9 mm). Although there was no difference between the IPSS groups in BWT (P = 0.325), it was statistically significant between uroflowmetry study groups (P < 0.01). CONCLUSIONS: BWT seems to be significantly increased in men who have Q (max) values smaller than 10 ml/s.
AIM: To evaluate the association between lower urinary tract symptoms (LUTS) severity and bladder wall thickness (BWT). MATERIALS AND METHODS: The study included 155 patients referred to outpatient clinics for LUTS. Patients were divided into three groups due to their IPSS. Group A included the patients with mild symptoms, group B included patients with moderate symptoms and group C included patients with severe symptoms. The patients were again divided into two groups due to their uroflowmetry results. Group 1 included the patients whose Q (max) </= 10 ml/s and group 2 included the patients whose Q (max) > 10 ml/s. RESULTS: The mean BWT was 4.14 + 1.03 mm (from 3 to 9 mm). Although there was no difference between the IPSS groups in BWT (P = 0.325), it was statistically significant between uroflowmetry study groups (P < 0.01). CONCLUSIONS: BWT seems to be significantly increased in men who have Q (max) values smaller than 10 ml/s.
Authors: J J de la Rosette; G Alivizatos; S Madersbacher; M Perachino; D Thomas; F Desgrandchamps; M de Wildt Journal: Eur Urol Date: 2001-09 Impact factor: 20.096
Authors: T L Tammela; W Schäfer; D M Barrett; P Abrams; H Hedlund; H J Rollema; A Matos-Ferreira; J Nordling; R Bruskewitz; P Miller; R Kirby; J T Andersen; C Jacobsen; G J Gormley; M P Malice; M A Bach Journal: Neurourol Urodyn Date: 1999 Impact factor: 2.696